ArticleIDCases2025
Primary pleural hydatid cyst: A rare presentation of echinococcosis with diagnostic and therapeutic insights.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hydatid disease, which is caused by Echinococcus granulosus, mainly impacts the liver and lungs. It is extremely uncommon for the pleura to be primarily affected, and this presents difficulties for diagnosis because it resembles a malignant condition. This report underscores a distinctive instance of an isolated pleural hydatid cyst, focusing on diagnostic challenges, multidisciplinary management, and treatment results. Case presentation: A Lebanese man aged 60, with no notable exposure history, showed up with an incidental pleural mass. Initial imaging indicated a potential malignancy based on rib erosion and rapid growth. A hydatid cyst was confirmed by a CT-guided biopsy, despite the presence of normal eosinophil counts and negative serology. The MRI ruled out hepatic/pulmonary involvement. Complete resolution, confirmed through serial imaging, was achieved with albendazole monotherapy (400 mg twice daily for five months). Discussion: This instance highlights how uncommon primary pleural hydatidosis is, as well as the shortcomings of serologic testing. The review of comparative literature shows just 12 documented instances, with our case being the first to exhibit rib erosion without hepatic or pulmonary involvement (Sudan et al., 2025 [2], Soner Gürsoy et al., 2009 [3], Brunetti et al., 2010 [7]). It encompasses radiological, pathological, and therapeutic nuances, promoting biopsy in equivocal cases (Santivanez et al., 2010 [1], Mardani et al., 2017 [6]). Conclusion: Even though primary pleural hydatid cysts are uncommon, they should be considered in the differential diagnoses of pleural masses, especially in areas where they are endemic. For an accurate diagnosis, histopathology and collaboration across disciplines are essential. For isolated cysts, albendazole monotherapy may be adequate; however, long-term monitoring is crucial (Mardani et al., 2017 [6], Qian, 1988 [9]).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.